Alzheimer’s disease

What is Donanemab?

Alzheimer’s disease, a debilitating neurodegenerative disorder, has long posed challenges for medical professionals and researchers. However, recent developments have brought hope with the approval of a new drug called Donanemab.   A Monoclonal Antibody for Alzheimer’s  Donanemab, a monoclonal antibody, ..

Month: 

Category: 

Abnormality of Astrocytes and Alzheimer’s Disease

Despite the availability of new drugs for treating early Alzheimer’s, predicting who will eventually develop the disease remains a significant challenge. However, a recent study has shed light on a potential solution. By analyzing blood tests that detect abnormal brain ..

Month: 

Category: 

Lecanemab Approved for Alzheimer’s Treatment

The US Food and Drug Administration (FDA) has approved lecanemab, a monoclonal antibody developed by Eisai and Biogen, for the treatment of Alzheimer’s disease. Lecanemab is the second drug to receive approval for the treatment of Alzheimer’s and the first ..

Month: 

Category: 

September 21: World Alzheimer’s Day

World Alzheimer Day was observed across the world on September 21 with the objective of raising awareness of the disease, common symptoms and risk factors. Highlights Alzheimer disease is a prevalent kind of dementia which gradually causes memory loss & ..

Month: 

Alzheimer Inhibitor developed by Jawaharlal Nehru Centre of Advanced Scientific Research

The scientists of Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR) operating under Department of Science and Technology has invented a natural product for Alzheimer disease. Significance Alzheimer’s is a disorder that accounts for more than 70% of all types ..

Month: 

IIIT Hyderabad’s researchers creates first-ever ‘Indian Brain Atlas (IBA)’

The researchers at the International Institute of Information Technology-Hyderabad (IIITH) have created the first ever Indian Brain Atlas (IBA). They stated that the average Indian brain is smaller in height, width, and volume as compared to the western and eastern ..

Sleep Deprivation and Alzheimer's Risk

The study published by the Researchers of the Washington University of the US published in the journal Science has found that sleep deprivation may increase the risk of developing Alzheimer’s disease. Alzheimer’s Disease Alzheimer’s disease is a chronic neurodegenerative disease that usually ..

Month: 

World Alzheimer’s Day observed globally

September 21 is World Alzheimer’s Day. The day is observed to spread awareness about Alzheimer’s disease across the globe. What is Alzheimer’s disease? Alzheimer’s disease is most common form of dementia (loss of memory). The disease, caused by the degeneration ..

Month: